Drug profile · INN
eslicarbazepine acetate
ZEBINIX
eslicarbazepine acetate (ZEBINIX) is a sodium channel alpha subunit blocker. Associated with S.A.. Route of administration: oral. Current US regulatory status: approved.
Drug details — eslicarbazepine acetate
- US status
- approved
- Class
- Nervous system (N03)
- Route
- ORAL
- Patents
- 14
- Programs
- 1
- Data quality
- 0.89
Quick answer
eslicarbazepine acetate (ZEBINIX) is a sodium channel alpha subunit blocker. Associated with S.A.. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Sodium channel alpha subunit blocker
Primary target: Sodium channel alpha subunit
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12263227
Optimized mRNA encoding CAS9 for use in LNPs
granted -
US 12227763
Methods and compositions for treating cancer
granted -
US 12188060
Messenger RNA encoding Cas9 for use in genome-editing systems
granted -
US 12016932
Gene editing for hemophilia A with improved factor VIII expression
granted -
US 11833225
Methods and compositions for efficient gene deletion
granted -
US 11827877
Compositions and methods for genomic editing by insertion of donor polynucleotides
granted -
US 11649438
Methods and compositions for treating cancer
granted -
US 11529427
Gene editing for hemophilia A with improved factor VIII expression
granted -
US 11332760
Compositions and methods for genomic editing by insertion of donor polynucleotides
granted -
US 11254912
Methods and compositions for treating cancer
granted -
MX 2013007491
GRANULATES COMPRISING ESLICARBAZEPINE ACETATE.
granted -
CA 2723411
PROCEDE
granted -
TW 200942531
Crystal forms of a nitrocatechol
granted -
WO 2009084970
3-N-PHÉNYL-1,3,4-OXADIAZOLONES 5-O-SUBSTITUÉES POUR UNE UTILISATION MÉDICALE
granted
Frequently asked questions
What is eslicarbazepine acetate?
eslicarbazepine acetate (ZEBINIX) is a sodium channel alpha subunit blocker. Associated with S.A.. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for eslicarbazepine acetate?
ZEBINIX is a marketed brand name for eslicarbazepine acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of eslicarbazepine acetate?
eslicarbazepine acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.